As an example of how different drugs promote the readthrough of different PTCs, we consider the commonly mutated tumor suppressors TP53 and PTEN (Fig. 3d, Extended Data Fig. 3f and Supplementary Table 5). The gene discussed is TP53; the disease is neoplasm.